ENTOS
Live / Applied — Statement of use — registration review complete (as of 28 Sept 2025)
What this means for you
Not registered yet, but its 14 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97980623
- Mark type
- Stylized text
- Filed
- 14 Sept 2022
- Published for opposition
- 07 May 2024
- Attorney of record
- Theodore R. Remaklus
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparations and substances, namely, human vaccines; chronic diseases, namely, chronic neurological and nervous system diseases and other mental illnesses, chronic eye diseases, chronic muscle diseases, and cancers in the nature of hematological cancers and solid organ cancers; vaccines that are viral, bacterial, fungal for human use; therapeutic and preventative cancer vaccines for human use; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the diagnosis, treatment and prevention of a variety of diseases and disorders, namely, inflammatory muscle diseases and disorders, diabetes, obesity, metabolic diseases and disorders, namely, metabolic enzyme deficiencies, diabetes, muscular dystrophy, genetic diseases and disorders, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, respiratory diseases and disorders, rare and orphan diseases, and rare genetic diseases and disorders, namely, rare respiratory, pulmonary and lung diseases, rare liver diseases, rare eye diseases, rare muscle diseases
Owner
- Entos Pharmaceuticals Inc., Edmonton, Alberta, CA
- Entos Pharmaceuticals Inc., Edmonton, Alberta, CA
Prosecution history
- 28 Sept 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Sept 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jun 2025 — USE AMENDMENT FILED
- 05 Sept 2025 — DIVISIONAL PROCESSING COMPLETE
- 30 Jun 2025 — DIVISIONAL REQUEST RECEIVED
- 30 Jun 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 30 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 07 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Mar 2025 — SOU EXTENSION 1 GRANTED
- 30 Dec 2024 — SOU EXTENSION 1 FILED
- 30 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 07 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Oct 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Oct 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED